Abstract
Purpose: To investigate the treatment results and analyze the prognostic factors for patients with medulloblastoma (MB) treated by surgery and postoperative radiation therapy (RT).
Methods and Materials: Thirty-five patients of MB receiving surgery followed by RT from February 1986 to September 1999 were reviewed. Their median age was 12 years with a slight male predominance. Twenty-four (69%) patients had total resection of tumor. Most (86%) cases received craniospinal irradiation (CSI). Adequate dose (craniospinal dose ≥ 30 Gy and posterior fossa dose ≥ 50 Gy) was given in 26 (74%) patients.
Results: The median survival duration was 48 months. The 5-year and 10-year overall survival rates were 63% and 40%, respectively. Univariate analysis revealed that stage, shunt surgery, RT dose, and protracted RT course were significant factors in predicting overall survival (OS), disease-free survival (DFS), and/or posterior fossa control (PFC). Multivariate analysis showed that RT dose affected OS and PFC independently, stage influenced OS and DFS, while protracted RT course impacted DFS. A total of 20 cases developed disease relapse. The median time to relapse was 18 months. The posterior fossa (10 cases) was the most common site of first failure, followed by the subfrontal lobe (7 cases), spine (6 cases), and other areas (4 cases).
Conclusion: Our results were compatible with others, except that more subfrontal relapses were found. Surgical resection followed by standard dose and adequate margin of CSI are recommended as the mainstays of treatment.
Similar content being viewed by others
References
Rorke LB: The cerebellar medulloblastoma and it relationship to primitive neuroectodermal tumors. J Neuropathol Exp Neurol 42: 1-15, 1997
Wolff JE, Huettermann U, Ritter J, Straeter R, Palm D, Duebe C, Kraehling KH, Jurgens H: Medulloblastoma: experience of a single institution. Klin Padiatr 210: 234-238, 1998
Berry MP, Jenkin RD, Keen CW, Nair BD, Simpson WJ: Radiation treatment for medulloblastoma: A 21 years review. J Neurosurg 55: 43-51, 1981
Russell DS, Rubinstein LJ: Pathology of Tumours of the Nervous System. Williams & Wilkins, Baltimore, 1989, p 251
Cutler EC, Sosman MC, Vaughan WW: Place of radiation in treatment of cerebellar medulloblastoma: Report of 20 cases. Am J Roentgenol Radium Ther 35: 429-453, 1936
Paulino AC: Radiotherapeutic management of medulloblastoma. Oncology 11: 813-823, 1997
Chang CH, Housepian EM, Herbert C Jr: An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 93: 1351-1359, 1969
delCharco JO, Bolek TW, McCollough WM, Maria BL, Kedar A, Braylan PC, Mickle JP, Buatti JM, Mendenhall NP, Marcus RB: Medulloblastoma: time-dose relationship based on a 30-year review. Int J Radiat Oncol Biol Phys 42: 147-154, 1998
Chan AW, Tarbell NJ, Black PM, Louis DN, Frosch MP, Ancukiewicz M, Chapman P, Loeffler JS: Adult medulloblastoma: prognostic factors and patterns of relapse. Neurosurgery 47: 623-631, 2000
Jenkin D, Goddard K, Armstrong D, Becker L, Berry M, Chan H, Doherty M, Greenberg M, Hendruck B, Hoffmann H: Posterior fossa medulloblastoma in childhood: treatment results and a proposal for a new staging system. Int J Radiat Oncol Biol Phys 19: 265-274, 1990
Albright AL, Wisoff LM, Zeltzer PM, Boyett JM, Rorke LB, Stanley P: Effects of medulloblastoma resections on outcome in children: a report from the Children's Cancer Group. Neurosurgery 38: 265-271, 1996
Evans AE, Jenkin RD, Sposto R, Ortega JA, Wilson CB, Wara W, Ertel IJ, Kramer S, Chang CH, Leikin SL: The treatment of medulloblastoma: results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine and prednisolone. J Neurosurg 72: 572-582, 1990
Le QT, Weil MD, Wara WM, Lamborn KR, Prados MD, Edwards MS, Gutin PH: Adult medulloblastoma: an analysis of survival and prognostic factors. Cancer J Sci Am 3: 238-245, 1997
Jenkin D, Shabanah MA, Shail EA, Gray A, Hassounah M, Khafaga Y, Mustafa M, Schultz H: Prognostic factors for medulloblastoma. Int J Radiat Oncol Biol Phys 47: 573-584, 2000
Raimondi AJ, Tomita T: Medulloblastoma in childhood: comparative results of partial and total resection. Child Brain 5: 310-328, 1979
Sutton LN, Phillips PC, Molloy PT: Surgical management of medulloblastoma. J Neurooncol 29: 9-21, 1996
Whelan HT, Krouwer HG, Schmidt MH, Reichert KW, Kovnar EH: Current therapy and new perspectives in the treatment of medulloblastoma. Pediatr Neurol 18: 103-115, 1998
Silverman CL, Simpson JR: Cerebellar medulloblastoma: the importance of posterior fossa dose to survival and patterns of failure. Int J Radiat Oncol Biol Phys 8: 1869-1876, 1982
Deutsch M, Thomas PR, Krischer J, Boyett JM, Albright L, Aronin P, Langston J, Allen JC, Packer RJ, Linggood R, Mulhern R, Stanley P, Stehbens JA, Duffner P, Kun L, Rorke L, Cherlow J, Freidman H, Finlay JL, Vietti T: Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with lowstage medulloblastoma. A Combined Children's Cancer Group-Pediatric Oncology Group Study. Pediatr Neurosurg 24: 167-176, 1996
Thomas PR, Deutsch M, Kepner JL, Boyett JM, Krischer J, Aronin P, Albright L, Allen JC, Packer RJ, Linggood R, Mulhern R, Stehbens JA, Langston J, Stanley P, Duffner P, Rorke L, Cherlow J, Friedman HS, Finlay JL, Vietti TJ, Kun LE: Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J Clin Oncol 18: 3004-3011, 2000
Goldwein JW, Radcliffe J, Johnson J, Moshang T, Packer RJ, Sutton LN, Rorke LB, D'Angio GJ: Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma). Int J Radiat Oncol Biol Phys 34: 899-904, 1996
Albright AL: The value of precraniotomy shunts in children with posterior fossa tumors. Clin Neurosurg 30: 278-285, 1982
David KM, Casey ATH, Hayward RD, Harkness WFJ, Phipps K, Wade AM: Medulloblastoma: is the 5-year survival rate improvingč A review of 80 cases from a single institution. J Neurosurg 86: 13-21, 1997
Lee M, Wisoff JH, Abbott R, Freed D, Epstein FJ: Management of hydrocephalus in children with medulloblastoma: prognostic factors for shunting. Pediatr Neurosurg 20: 240-247, 1994
Saran FH, Driever PH, Thilmann C, Mose S, Wilson P, Sharpe G, Adamietz IA, Bottcher HD: Survival of very young children with medulloblastoma (primitive neuroectodermal tumor of the posterior fossa) treated with craniospinal irradiation. Int J Radiat Oncol Biol Phys 42: 959-967, 1998
Allen JC, Epstein F: Medulloblastoma and other primary malignant neuroectodermal tumors of the CNS: the effect of patient's age and extent of disease on prognosis. J Neurosurg 57: 446-451, 1982
Gentet JC, Bouffet E, Doz F, Tron P, Roche H, Thyss A, Plantaz D, Stephan JL, Mottolese C, Ponvert D: Preirradiation chemotherapy including “eight drugs in a day” regimen and high-dose methotrexate in childhood medulloblastoma: results of the M7 French Cooperative Study. J Neurosrug 82: 608-614, 1995
Choux M, Lena G, Hassoun J: Prognosis and long-term follow-up in patients with medulloblastoma. Clin Neurosurg 30: 246-277, 1983
Weil MD, Lamborn K, Edwards MS, Wara WM: Influence of a child's sex on medulloblastoma outcome. JAMA 279: 1474-1476, 1998
Fukunaga-Johnson N, Lee JH, Sandler HM, Robertson P, McNeil E, Goldwein JW: Patterns of failure following treatment for medulloblastoma: is it necessary to treat the entire posterior fossač Int J Radiat Oncol Biol Phys 42: 143-146, 1998
Hartsell WF, Gajjar A, Heideman RL, Langston JA, Sanford RA, Walter A, Jones D, Chen G, Kun LE: Patterns of failure in children with medulloblastoma: effects of preirradiation chemotherapy. Int J Radiat Oncol Biol Phys 39: 15-24, 1997
Miralbell R, Bleher A, Huguenin P, Ries G, Kann R, Mirimanoff RO, Notter M, Nouet P, Bieri S, Thum P, Toussi H: Pediatric medulloblastoma: radiation treatment technique and patterns of failure. Int J Radiat Oncol Biol Phys 37: 523-529, 1997
Halperin EC: Impact of radiation technique upon the outcome of treatment for medulloblastoma. Int J Radiat Oncol Biol Phys 36: 233-239, 1996
Carrie C, Hoffstetter S, Gomez F, Moncho V, Doz F, Alapetite C, Murraciole X, Maire JP, Benhassel M, Chapet S, Quetin P, Kolodie H, Lagrange JL, Cuillere JC, Habrand JL: Impact of targeting deviations on outcome in medulloblastoma: study of the French Society of Pediatric Oncology (SFOP). Int J Radiat Oncol Biol Phys 45: 435-439, 1999
Carrie C, Alapetite C, Mere P, Aimard L, Pons A, Kolodie H, Seng S, Lagrange JL, Pontvert D, Pignon T: Quality control of radiotherapeutic treatment of medulloblastoma in a multicentric study: the contribution of radiotherapy technique to tumor relapse. Radiother Oncol 24: 77-81, 1992
Donnal J, Halperin EC, Friedman HS, Bokyo OB: Subfrontal recurrence of medulloblastoma. Am J Neurosurg 13: 1617-1618, 1992
Hardy DG, Hope-Stone HF, McKenzie CG, Scholtz CL: Recurrence of medulloblastoma after homogeneous field radiotherapy. Report of three cases. J Neurosurg 49: 434-440, 1978
Jereb B, Krishnaswami S, Reid A, Allen JC: Radiation for medulloblastoma adjusted to prevent recurrence to the cribriform plate region. Cancer 54: 602-604, 1984
Lowery GS, Kimball JC, Patterson RB, Raben M: Extraneural metastases from cerebellar medulloblastoma. Am J Pediatr Hematol Oncol 4: 259-262, 1982
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sun, LM., Yeh, SA., Wang, CJ. et al. Postoperative Radiation Therapy for Medulloblastoma – High Recurrence Rate in the Subfrontal Region. J Neurooncol 58, 77–85 (2002). https://doi.org/10.1023/A:1015865614640
Issue Date:
DOI: https://doi.org/10.1023/A:1015865614640